Avadel Pharmaceuticals (AVDL)
NASDAQ: AVDL
· Real-Time Price · USD
13.65
0.15 (1.11%)
At close: Aug 15, 2025, 11:14 AM
Avadel Pharmaceuticals Revenue
Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending March 31, 2025, Avadel Pharmaceuticals generated $52.51M in revenue.
Revenue (ttm)
169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
899.56K
Employees
188
Market Cap
1.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|